BR0107912A - Composto, composições, e, métodos para tratar ou prevenir o c ncer ou doença neoplástica, método para inibir o desenvolvimento de uma célula cancerìgena ou célula neoplástica, método para tratar ou prevenir uma infecção viral em um paciente, e para inibir a replicação ou a infectividade de um vìrus - Google Patents
Composto, composições, e, métodos para tratar ou prevenir o c ncer ou doença neoplástica, método para inibir o desenvolvimento de uma célula cancerìgena ou célula neoplástica, método para tratar ou prevenir uma infecção viral em um paciente, e para inibir a replicação ou a infectividade de um vìrusInfo
- Publication number
- BR0107912A BR0107912A BR0107912-3A BR0107912A BR0107912A BR 0107912 A BR0107912 A BR 0107912A BR 0107912 A BR0107912 A BR 0107912A BR 0107912 A BR0107912 A BR 0107912A
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- inhibiting
- cancer
- preventing
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/491,712 US6407244B1 (en) | 2000-01-26 | 2000-01-26 | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
| PCT/CA2001/000085 WO2001055131A2 (en) | 2000-01-26 | 2001-01-24 | Prodigiosin-derivatives as neoplastic and anti-viral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0107912A true BR0107912A (pt) | 2002-12-10 |
Family
ID=23953337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0107912-3A BR0107912A (pt) | 2000-01-26 | 2001-01-24 | Composto, composições, e, métodos para tratar ou prevenir o c ncer ou doença neoplástica, método para inibir o desenvolvimento de uma célula cancerìgena ou célula neoplástica, método para tratar ou prevenir uma infecção viral em um paciente, e para inibir a replicação ou a infectividade de um vìrus |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6407244B1 (de) |
| EP (2) | EP1431286A3 (de) |
| JP (1) | JP2003523352A (de) |
| KR (1) | KR20020072295A (de) |
| CN (1) | CN1419553A (de) |
| AT (1) | ATE269859T1 (de) |
| AU (1) | AU780647B2 (de) |
| BR (1) | BR0107912A (de) |
| CA (1) | CA2398173A1 (de) |
| CZ (1) | CZ20022604A3 (de) |
| DE (1) | DE60103978D1 (de) |
| IL (1) | IL150817A0 (de) |
| MX (1) | MXPA02007271A (de) |
| NO (1) | NO20023486L (de) |
| NZ (1) | NZ520361A (de) |
| PL (1) | PL356932A1 (de) |
| SK (1) | SK10952002A3 (de) |
| WO (1) | WO2001055131A2 (de) |
| ZA (1) | ZA200205838B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407244B1 (en) | 2000-01-26 | 2002-06-18 | Gemin X Biotechnologies Inc. | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
| US20040014987A1 (en) * | 2000-01-26 | 2004-01-22 | Gemin X Biotechnologies Inc. | Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases |
| WO2003008410A2 (en) * | 2001-07-18 | 2003-01-30 | Gemin X Biotechnologies Inc. | Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| US20030119894A1 (en) * | 2001-07-20 | 2003-06-26 | Gemin X Biotechnologies Inc. | Methods for treatment of cancer or neoplastic disease and for inhibiting growth of cancer cells and neoplastic cells |
| WO2004002367A1 (fr) * | 2002-06-27 | 2004-01-08 | Microport Medical (Shanghai) Co., Ltd. | Stent eluant des medicaments |
| CA2527583C (en) * | 2003-05-30 | 2013-12-17 | Giorgio Attardo | Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| EP1836165B1 (de) * | 2004-12-28 | 2014-02-12 | Gemin X Pharmaceuticals Canada Inc. | Dipyrrolverbindungen, zusammensetzungen und verfahren zur behandlung von krebs oder viruskrankheiten |
| JP2010533205A (ja) * | 2007-07-12 | 2010-10-21 | トラガラ ファーマシューティカルズ，インク． | 癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物 |
| EP2224919A4 (de) * | 2007-11-28 | 2011-09-14 | Tragara Pharmaceuticals Inc | Verfahren und zusammensetzungen zur behandlung von krebs, tumoren und tumor-bedingten erkrankungen |
| CN103145719B (zh) * | 2013-02-27 | 2015-04-29 | 中国科学院化学研究所 | 灵菌红素衍生物的制备方法 |
| CA2986547C (en) | 2014-09-29 | 2023-03-21 | The Penn State Research Foundation | A compound for anti-cancer therapy that acts by targeting gof mutant p53 and stimulates p73 to restore the p53 pathway signaling |
| US10111554B2 (en) | 2015-03-20 | 2018-10-30 | Meltz, LLC | Systems for and methods of controlled liquid food or beverage product creation |
| US10314320B2 (en) | 2015-03-20 | 2019-06-11 | Meltz, LLC | Systems for controlled liquid food or beverage product creation |
| KR101785428B1 (ko) | 2016-04-21 | 2017-10-16 | (주) 마이크로프랜드 | 반도체소자 테스트소켓 |
| WO2018200922A1 (en) | 2017-04-27 | 2018-11-01 | Meltz, LLC | Method for centrifugal extraction and apparatus suitable for carrying out this method |
| CN109942559A (zh) * | 2019-03-08 | 2019-06-28 | 上海大学 | 呋喃二联吡咯化合物及其制备方法 |
| US11724849B2 (en) | 2019-06-07 | 2023-08-15 | Cometeer, Inc. | Packaging and method for single serve beverage product |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4266028A (en) * | 1979-02-21 | 1981-05-05 | Kirin Beer Kabushiki Kaisha | Process for preparation of prodigiosin |
| JPS55162768A (en) * | 1979-06-06 | 1980-12-18 | Kirin Brewery Co Ltd | Carcinostatic |
| JPS6134403A (ja) | 1984-07-26 | 1986-02-18 | Nec Corp | 光干渉計 |
| JPS61280429A (ja) | 1985-06-06 | 1986-12-11 | Chugai Pharmaceut Co Ltd | 免疫抑制剤 |
| JPH02250828A (ja) | 1989-03-23 | 1990-10-08 | Nippon Kayaku Co Ltd | 新規免疫抑制剤 |
| JPH0586374A (ja) | 1991-09-26 | 1993-04-06 | Teikoku Sekiyu Kk | 炭水化物を可燃性のガスに分解する方法 |
| GB9326284D0 (en) | 1993-12-23 | 1994-02-23 | Erba Carlo Spa | Pyrrolydenemethyl-derivatives and process for their preparation |
| JPH0930967A (ja) | 1995-07-17 | 1997-02-04 | Chugai Pharmaceut Co Ltd | 抗潰瘍剤 |
| GB9603212D0 (en) | 1996-02-15 | 1996-04-17 | Pharmacia Spa | Process for the preparation of 2,2'-bipyrrolyl-pyrromethane derivatives |
| GB9619706D0 (en) | 1996-09-20 | 1996-11-06 | Pharmacia Spa | Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole comp und |
| JP3949198B2 (ja) | 1996-10-23 | 2007-07-25 | 赤穂化成株式会社 | Ｖ−ＡＴＰａｓｅ 脱共役 Ｈ＋ ポンプ阻害剤 |
| JP3949196B2 (ja) | 1996-10-23 | 2007-07-25 | 赤穂化成株式会社 | 免疫抑制剤 |
| GB9705035D0 (en) | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| KR100252197B1 (ko) | 1997-09-20 | 2000-04-15 | 박호군 | 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신 |
| JPH11209283A (ja) | 1997-10-01 | 1999-08-03 | Ako Kasei Co Ltd | 抗癌剤 |
| GB9726130D0 (en) | 1997-12-10 | 1998-02-11 | Pharmacia & Upjohn Spa | 2,2'-BI-1H-pyrrole derivatives useful in the treatment of leukemia brought on by HTLV-I |
| GB9802745D0 (en) | 1998-02-09 | 1998-04-08 | Pharmacia & Upjohn Spa | Benzyloxy prodigiosine compounds |
| US6407244B1 (en) | 2000-01-26 | 2002-06-18 | Gemin X Biotechnologies Inc. | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases |
-
2000
- 2000-01-26 US US09/491,712 patent/US6407244B1/en not_active Expired - Lifetime
-
2001
- 2001-01-24 AT AT01902193T patent/ATE269859T1/de not_active IP Right Cessation
- 2001-01-24 AU AU29912/01A patent/AU780647B2/en not_active Ceased
- 2001-01-24 CN CN01807066A patent/CN1419553A/zh active Pending
- 2001-01-24 KR KR1020027009667A patent/KR20020072295A/ko not_active Application Discontinuation
- 2001-01-24 DE DE60103978T patent/DE60103978D1/de not_active Expired - Lifetime
- 2001-01-24 SK SK1095-2002A patent/SK10952002A3/sk unknown
- 2001-01-24 CZ CZ20022604A patent/CZ20022604A3/cs unknown
- 2001-01-24 WO PCT/CA2001/000085 patent/WO2001055131A2/en active IP Right Grant
- 2001-01-24 CA CA002398173A patent/CA2398173A1/en not_active Abandoned
- 2001-01-24 JP JP2001560990A patent/JP2003523352A/ja active Pending
- 2001-01-24 IL IL15081701A patent/IL150817A0/xx unknown
- 2001-01-24 PL PL01356932A patent/PL356932A1/xx not_active Application Discontinuation
- 2001-01-24 EP EP04003643A patent/EP1431286A3/de not_active Withdrawn
- 2001-01-24 BR BR0107912-3A patent/BR0107912A/pt not_active IP Right Cessation
- 2001-01-24 MX MXPA02007271A patent/MXPA02007271A/es active IP Right Grant
- 2001-01-24 NZ NZ520361A patent/NZ520361A/en unknown
- 2001-01-24 EP EP01902193A patent/EP1255753B1/de not_active Expired - Lifetime
-
2002
- 2002-04-04 US US10/116,094 patent/US6602879B2/en not_active Expired - Lifetime
- 2002-07-22 ZA ZA200205838A patent/ZA200205838B/en unknown
- 2002-07-22 NO NO20023486A patent/NO20023486L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1255753B1 (de) | 2004-06-23 |
| EP1431286A3 (de) | 2004-07-28 |
| JP2003523352A (ja) | 2003-08-05 |
| EP1431286A2 (de) | 2004-06-23 |
| MXPA02007271A (es) | 2004-07-30 |
| PL356932A1 (en) | 2004-07-12 |
| EP1255753A2 (de) | 2002-11-13 |
| CZ20022604A3 (cs) | 2003-01-15 |
| US6602879B2 (en) | 2003-08-05 |
| CA2398173A1 (en) | 2001-08-02 |
| US20030009032A1 (en) | 2003-01-09 |
| NO20023486L (no) | 2002-09-04 |
| ZA200205838B (en) | 2004-03-08 |
| NO20023486D0 (no) | 2002-07-22 |
| ATE269859T1 (de) | 2004-07-15 |
| SK10952002A3 (sk) | 2003-01-09 |
| NZ520361A (en) | 2004-02-27 |
| CN1419553A (zh) | 2003-05-21 |
| DE60103978D1 (de) | 2004-07-29 |
| WO2001055131A3 (en) | 2002-03-07 |
| KR20020072295A (ko) | 2002-09-14 |
| WO2001055131A2 (en) | 2001-08-02 |
| AU2991201A (en) | 2001-08-07 |
| IL150817A0 (en) | 2003-02-12 |
| US6407244B1 (en) | 2002-06-18 |
| AU780647B2 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0107912A (pt) | Composto, composições, e, métodos para tratar ou prevenir o c ncer ou doença neoplástica, método para inibir o desenvolvimento de uma célula cancerìgena ou célula neoplástica, método para tratar ou prevenir uma infecção viral em um paciente, e para inibir a replicação ou a infectividade de um vìrus | |
| PT1404347E (pt) | Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| BRPI0410870A (pt) | compostos trieterocìclicos, composições, e métodos para tratar cáncer ou doenças virais | |
| AP1782A (en) | Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus. | |
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| NO20052130L (no) | Sterk inhibitor for HCV-serin-protease | |
| BRPI0409227B8 (pt) | "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)" | |
| DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
| BRPI0516972A (pt) | composto, uso do mesmo, composição farmacêutica, método para inibir a polimerase do vìrus da hepatite c e/ou de tratar ou prevenir uma doença devido ao vìrus da hepatite c, e, processo para preparar um composto | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| BR9711095A (pt) | Composto de ciclopentano substituìdo, composição e método para inibir neuraminidase de vìrus influenza e método para tratar infecção de vìrus influenza | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| CY1108061T1 (el) | Παραγωγα κιναζολινης ως src αναστολεις κινασης τυροσινης | |
| BRPI0508079A (pt) | composto ou uma forma cristalina ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos de tratar ou prevenir uma infecção viral com hepatite c em um mamìfero e de inibir replicação de um vìrus da hepatite c | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| BRPI0515897A (pt) | composto, uso do mesmo, composição farmacêutica, e, método para a terapia de dor em um animal de sangue quente, e para a preparação de um composto | |
| NO20021337D0 (no) | 4-benzylaminoquinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlersom inneholder disse forbindelser og deres anvendelse | |
| ATE301997T1 (de) | Antivirale therapie | |
| BR0315713A (pt) | Composto, processo para a preparação do composto, composição farmacêutica, métodos para reduzir a glicose, para a prevenção ou para o tratamento de doenças e uso do composto | |
| DE60104288D1 (de) | Antivirale therapie | |
| BR9902049A (pt) | Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina. | |
| BR9806923A (pt) | Composto de terbenzimidazol, uso do mesmo, composi;cão farmacêutica, e, processo teapêutico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2008 DE 30/06/2009. |